Sandostatin LAR (octreotide) 10 mg, Novartis, Switzerland, original Sandostatin LAR (octreotide) is used for approved indications including certain neuroendocrine and carcinoid tumors. International medicine delivery within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
SANDOSTATIN LAR (OCTREOTID)
10 MG - 280$
20 MG - 450$
indications
- Acromegaly (in patients with experience using the drug Sandostatin ®):
- treatment of the main manifestations of the disease in cases where there is no sufficient effect from surgical treatment or radiation therapy
- treatment between courses of radiation therapy until its effectiveness is achieved.
- Symptoms of functional endocrine tumors of the gastrointestinal tract (in patients with experience using the drug Sandostatin ®):
- carcinoid tumors with existing Carcinoid syndrome;
- VIPomas;
- glucagonoma;
- Gastrinoma / Zollinger-Ellison syndrome,
- insulinoma to control hypoglycemia in the preoperative period, as well as for maintenance therapy
- somatoliberinomas (tumors that synthesize growth hormone releasing factor).
- Metastatic neuroendocrine tumors of the intestine or in the case of an unknown location of the primary tumor, when primary sites other than the intestine have been excluded.
- Trade name:Sandostatin LAR
- Chemical name:Octreotide
- Dosage:30 mg
- Dosage form:Vial
No reviews yet
